Dana Farber Cancer Institute opposition analysis

COMPANY ANALYSIS

Latest patents of Dana Farber Cancer Institute opposed by its competitors

Patent:
Grant Date:
Dec 13, 2017
Title:
Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd-1)Pathway
Oppositions:
3

Competitors of Dana Farber Cancer Institute

JANSSEN SCIENCES IRELAND UC

REGENERON PHARMACEUTICALS, INC.

SANOFI

Want to track Dana Farber Cancer Institute?

Feel free to send us a message here and we will get back to you